Skip to Main Content
Hospital Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Guide to Cannabis training for pharmacists that offers 16 hours of ACPE-accredited training based on the latest, science-based cannabis research. Only $199. Learn More!
  1. Home
  2. Browse
  3. Psychiatry
  4. Depression
  5. Drugs
  6. Bupropion

Bupropion

  • ADHD (36)
  • Agitation (1)
  • Anxiety (25)
  • Bipolar Disorder (8)
  • Depression (146)
    • Cardiovascular Disease and Depression (8)
    • Drugs (130)
      • Atypical Antipsychotics (44)
      • Benzodiazepines (36)
      • Bupropion (27)
      • MAOIs (9)
      • SNRIs (49)
      • SSRIs (74)
      • TCAs (30)
      • Typical Antipsychotics (1)
    • Natural Medicines/Supplements (9)
    • Pediatrics (9)
    • Post-Traumatic Stress Disorder (8)
    • Pregnancy (4)
    • Seasonal Affective Disorder (1)
    • Treatment-Resistant Depression (13)
  • Mental Health (24)
  • Resources (130)
  • Schizophrenia (38)
  • Sleep Disorders (55)
  • Substance Use Disorder (161)
16 - 27 of 27 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: SSRIs and SNRIs and Bleeding Risk: Focus on Drug Interactions November 2014
Chart: Comparison of Antidepressants December 2013
Commentary: Treatment-Resistant Depression September 2013
Chart: Comparison of Bupropion Products December 2012
Commentary: Chantix (Varenicline): New Safety Information and Instructions For Use August 2011
Commentary: Chantix (Varenicline) and Risk of Cardiovascular Events August 2011
Guideline: Treating Tobacco Use and Dependence (2008 Update) August 2011
PL Voices: New Warnings About Chantix August 2011
Guideline: Practice Guideline for the Treatment of Patients with Major Depressive Disorder (2010) July 2011
Archive: A Note from Your Pharmacist: How to Write for Bupropion to Get the Product You Want February 2011
Guideline: Practice Guideline for the Treatment of Patients With Major Depressive Disorder (2010) November 2010
Commentary: Depression Guidelines: Overview of Pharmacotherapy November 2010
  • « Prev
  • 1
  • 2
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved